ONL Therapeutics   Report issue

For profit Phase 1
Founded: Ann Arbor MI United States (2011)

Organization Overview

First Clinical Trial
2019
NCT03780972
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

ONL Therapeutics